Table I.
Association between lncRNA ENST00000500843 expression and clinicopathological features of patients with lung adenocarcinoma.
| lncRNA ENST00000500843 | |||
|---|---|---|---|
| Clinical characteristic | Low expression (n=45) | High expression (n=11) | P-value |
| Sex | |||
| Male | 19 | 4 | 0.990 |
| Female | 26 | 7 | |
| Age, years | |||
| <60 | 25 | 6 | >0.999 |
| ≥60 | 20 | 5 | |
| Smoking status | |||
| Yes | 24 | 7 | 0.781 |
| No | 21 | 4 | |
| Tumor diameter, cm | |||
| <2 | 13 | 8 | 0.019 |
| ≥2 | 32 | 3 | |
| Pathological differentiation | |||
| Moderate and low | 36 | 4 | 0.012 |
| High | 9 | 7 | |
| Metastasis of lymph nodes | |||
| No | 15 | 8 | 0.041 |
| Yes | 30 | 3 | |
| TNM stage | |||
| I, II | 35 | 7 | 0.560 |
| III, IV | 10 | 4 | |
Independent Student's t-test and one-way ANOVA was used to compare the differences between two groups using SPSS software (version 18.0; SPSS, Inc.). Pathological differentiation was concluded by pathological pathologists from Shengjing Hospital of China Medical University using hematoxylin-eosin staining. TNM, Tumor-Node-Metastasis (22); lncRNA ENST00000500843, long noncoding RNA ENST00000500843.